NGF and nervous system disorder: Our data together with others’ studies also suggest that delta opioid agonists may be a potential lead compound for developing the NGF signaling activators and such NGF activators may be further developed for the prevention and treatment of NGF or other neurotrophic factor-dependent neurological disorders.